Literature DB >> 12297979

Frequency of the Amsterdam criteria in a regional German cohort of patients with colorectal cancer.

J Raedle1, M Schaffner, N Esser, S Sahm, J Trojan, S Kriener, A Brieger, H Nier, H Bockhorn, P L Berg, B Frick, D Schäfer, S Zeuzem.   

Abstract

Estimates of the colon cancer burden associated with hereditary nonpolyposis colorectal cancer (HNPCC) vary from less than 1 % to more than 5 %. Amsterdam criteria fulfilled within a kindred (classic Amsterdam and Amsterdam II criteria) are widely used to identify patients prone to HNPCC. The present study was initiated to assess the frequency of the Amsterdam criteria within a regional German cohort of 207 patients with a history of colorectal cancer (CRC). Data on individual and family cancer histories were available in 154 patients (73 women, 81 men; mean age at diagnosis 62.4 +/- 13.3 years). A total of 843 first degree relatives have been identified within the kindreds of whom 121 had verified cancers. In 28 of 154 families (18 %), at least one first degree relative of the index patient had CRC. With respect to a typical family history, five kindreds (3.2 %) were likely to suffer from HNPCC on a clinical basis (4 kindreds met the classic Amsterdam criteria and one kindred the Amsterdam II criteria). Testing for microsatellite instability could additionally be performed in 4 of 5 patients who met the Amsterdam criteria and revealed DNA instability in 3 cases. Moreover, a missense mutation of MSH2 (Gly965Asp) was detected in one patient with microsatellite instability. Based on the classic Amsterdam and Amsterdam II criteria approximately 3 % of a regional German cohort of patients with CRC are likely to suffer from HNPCC. However, the final diagnosis of HNPCC can only be established by detection of pathogenic germline mutations within the DNA mismatch repair genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297979     DOI: 10.1055/s-2002-33419

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  4 in total

1.  Clinicopathological and molecular genetic analysis of HNPCC in China.

Authors:  Ding-Cun Luo; Qi Cai; Meng-Hong Sun; Yao-Zhong Ni; Shi-Chang Ni; Zhe-Jing Chen; Xiao-Yang Li; Chong-Wei Tao; Xue-Miao Zhang; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

2.  Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer.

Authors:  San-Jun Cai; Ye Xu; Guo-Xiang Cai; Peng Lian; Zu-Qing Guan; Shan-Jing Mo; Meng-Hong Sun; Qi Cai; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

3.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

4.  Population screening for hereditary and familial cancer syndromes in Valka district of Latvia.

Authors:  Andrejs Vanags; Ilze Strumfa; Andris Gardovskis; Viktors Borošenko; Arnis Aboliņš; Uldis Teibe; Genadijs Trofimovičs; Edvīns Miklaševičs; Jānis Gardovskis
Journal:  Hered Cancer Clin Pract       Date:  2010-10-29       Impact factor: 2.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.